Patel, "Development and Validation of HPTLC Method for Simultaneous Estimation of Levamisole Hydrochloride and Oxyclozanide in its Bulk and Pharmaceutical Dosage Form," Austin Chromatogr, vol.
Shabaraya, "Extractive spectrophotometric methods for the determination of levamisole hydrochloride," International Journal of PharmTech Research, vol.
Tao, "First-derivative spectrophotometric determination of the content of levamisole hydrochloride tablets Yaowu," Fenxi.
Gajjar, "Development and validation of derivative spectroscopic Method for the simultaneous estimation of mebendazole and levamisole hydrochloride in pharmaceutical formulations," International Journal of Pharmaceutical Chemistry and Analysis, vol.
Abbasifar, "Potentiometric sensing of levamisole hydrochloride based on molecularly imprinted polymer," Sensors and Actuators B: Chemical, vol.
Treatment with all 3 sublancin levels resulted in similar body weight to levamisole hydrochloride.
In addition, treatment with 10.0 mg/kg levamisole hydrochloride resulted in higher numbers of RBC, WBC, HGB, and platelets compared with the NC treatment.
However, no difference was observed in the body weight among the sublancin-treated groups and the MC group on day 11, a result similar to the effects of levamisole hydrochloride.
Six-week-old female BALB/c mice were separated into five groups and orally administered with sublancin (0.5, 1.0, and 2.0 mg/kg body weight/day) or 2.5 mg/kg levamisole hydrochloride (positive control) for 7 days.
Dogs in group A and B were respectively given Ivermectin and Levamisole hydrochloride at their recommended dose rate whereas no treatment was given to dogs in group C which acted as untreated control.
Levamisole hydrochloride (Ketrax tablet) was given orally at the rate of 15 mg/kg body weight to dogs of group B.
Levamisole hydrochloride at the rate of 15 mg/kg body weight caused decrease in EPG count 97.4 percent.